Literature DB >> 9654594

Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors.

P Athanassiadou1, V Sakellariou, E Petrakakou, P Athanassiades, C Zerva, A Liossi, S Michalas.   

Abstract

In view of the somewhat inconclusive nature of the reports of the role of Cathepsin D (Cath D) in ovarian carcinoma and its relationship with various other parameters of malignancy the present study was performed to aid in the further clarification of this role. One hundred freshly resected primary ovarian carcinomas of various histological types were studied for ER, PR and Cath D status and the results examined with respect to menopausal status, histology, size and lymph node invasion. In our series Cath D positivity was more frequent in serous than in other types of ovarian cancer but this Cath D positivity was not related to the frequency of lymph node invasion regardless of the size of the tumor. Nor was any association observed between Cath D positivity and ER or PR status of the tumors or the menopausal state of the patients. The reported prognostic value of Cath D, ER and PR is discussed as well as the distinction between tumor invasion by lymphatic channels and direct interstitial infiltration. It was concluded that Cath D may not play a role in the former mode but, as might be expected from its proteolytic properties, in local spread by means of tissue destruction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9654594     DOI: 10.1007/bf02904702

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  26 in total

1.  Direct evidence of importance of lysosomes in degradation of intracellular proteins.

Authors:  R T Dean
Journal:  Nature       Date:  1975-10-02       Impact factor: 49.962

2.  Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells.

Authors:  F Capony; C Rougeot; P Montcourrier; V Cavailles; G Salazar; H Rochefort
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.

Authors:  B Tholander; A Taube; A Lindgren; O Sjöberg; U Stendahl; A Kiviranta; K Hallman; L Holm; E Weiner; L Tamsen
Journal:  Gynecol Oncol       Date:  1990-10       Impact factor: 5.482

5.  Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells.

Authors:  I Touitou; V Cavaillès; M Garcia; A Defrenne; H Rochefort
Journal:  Mol Cell Endocrinol       Date:  1989-10       Impact factor: 4.102

Review 6.  Cathepsin D in breast cancer.

Authors:  H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1990-07       Impact factor: 4.872

7.  Survival of patients with ovarian cancer. Apart from stage and grade, tumor progesterone receptor content is a prognostic indicator.

Authors:  B J Slotman; J J Nauta; B R Rao
Journal:  Cancer       Date:  1990-08-15       Impact factor: 6.860

Review 8.  Cathepsin D in the malignant progression of neoplastic diseases (review).

Authors:  G Leto; N Gebbia; L Rausa; F M Tumminello
Journal:  Anticancer Res       Date:  1992 Jan-Feb       Impact factor: 2.480

9.  Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies.

Authors:  G Roos; G Landberg; J P Huff; R Houghten; Y Takasaki; E M Tan
Journal:  Lab Invest       Date:  1993-02       Impact factor: 5.662

10.  In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells.

Authors:  P Briozzo; M Morisset; F Capony; C Rougeot; H Rochefort
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

View more
  5 in total

1.  Combined in vivo molecular and anatomic imaging for detection of ovarian carcinoma-associated protease activity and integrin expression in mice.

Authors:  Harvey H Hensley; Navid A Roder; Shane W O'Brien; Laura E Bickel; Fang Xiao; Sam Litwin; Denise C Connolly
Journal:  Neoplasia       Date:  2012-06       Impact factor: 5.715

2.  Effect of Productive Human Papillomavirus 16 Infection on Global Gene Expression in Cervical Epithelium.

Authors:  Sa Do Kang; Sreejata Chatterjee; Samina Alam; Anna C Salzberg; Janice Milici; Sjoerd H van der Burg; Craig Meyers
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

Review 3.  Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications.

Authors:  Gaetano Leto; Francesca M Tumminello; Marilena Crescimanno; Carla Flandina; Nicola Gebbia
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 4.  Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis.

Authors:  Hui Luo; Saisai Li; Menghuang Zhao; Bo Sheng; Haiyan Zhu; Xueqiong Zhu
Journal:  Oncotarget       Date:  2017-05-30

5.  Correlation between estrogen receptor expression and prognosis in epithelial ovarian cancer: a meta-analysis.

Authors:  Zhaojun Shen; Hui Luo; Saisai Li; Bo Sheng; Menghuang Zhao; Haiyan Zhu; Xueqiong Zhu
Journal:  Oncotarget       Date:  2017-05-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.